Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
UNIVERSITE DE STRASBOURG has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are handled by 3 distinct examiners, which matches the count of 3 pending office actions. All of these matters are located within 1 distinct art unit, which is a lower count than the 3 distinct examiners involved.
The busiest examiner for the portfolio is ESPERON, NATHAN GREGORY: he is responsible for 1 busiest examiner pending action. This 1 busiest examiner pending action represents one of the 3 pending office actions currently active. Because the 3 pending office actions are split among 3 distinct examiners, each individual manages exactly one action. The 1 distinct art unit indicates that the 3 pending office actions share a common technical classification. Practitioners should observe that the 3 distinct examiners will each apply the standards of this 1 distinct art unit to their respective cases. The outcome of the 3 pending office actions will provide a view of how different examiners within the Medical Devices & Mechanical Engineering sector interpret the university's filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ESPERON, NATHAN GREGORY | 1 | 41.0% | +23.3% |
| RIOJA, MELISSA A | 1 | 49.5% | +53.8% |
| HULL, JAMES B | 1 | 45.4% | +52.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690250 | METHOD FOR TREATING A PRODUCT CONTAINING ASBESTOS | ESPERON, NATHAN GREGORY | — |
| 18293132 | METHOD FOR PRODUCING A MIXTURE OF ALKOXYLATED POLYPHENOLS AND USE OF SAID MIXTURE | RIOJA, MELISSA A | — |
| 18028053 | DEVICE FOR SIMULATING THE MOVEMENT OF AN ENDOSCOPE IN AN ENVIRONMENT | HULL, JAMES B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690250 | METHOD FOR TREATING A PRODUCT CONTAINING ASBESTOS | ESPERON, NATHAN GREGORY | — |
| 18293132 | METHOD FOR PRODUCING A MIXTURE OF ALKOXYLATED POLYPHENOLS AND USE OF SAID MIXTURE | RIOJA, MELISSA A | — |
| 18028053 | DEVICE FOR SIMULATING THE MOVEMENT OF AN ENDOSCOPE IN AN ENVIRONMENT | HULL, JAMES B | — |
| Art Unit | Apps |
|---|---|
| 3715 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18690250 | METHOD FOR TREATING A PRODUCT CONTAINING ASBESTOS | ESPERON, NATHAN GREGORY | — | §102§103§112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18293132 | METHOD FOR PRODUCING A MIXTURE OF ALKOXYLATED POLYPHENOLS AND USE OF SAID MIXTURE | RIOJA, MELISSA A | — | §103§112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18028053 | DEVICE FOR SIMULATING THE MOVEMENT OF AN ENDOSCOPE IN AN ENVIRONMENT | HULL, JAMES B | 3715 | §103§112 | Non-Final OA | — | Pending | Mar 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial